Today we explore Blarcamesine. What binding affinities make up the compound? What downstream effects can be deduced? How does this make Blarcamesine unique? All of these facets will be explored here.
As mentioned within the video, there are limitations to the analytic approach used within, being:
1. This approach does assume that many of the secondary binding affinities for Blarcamesine do in fact interact with and effect complimentary genes (confidence = moderate-high)
2. This does not take into account molecular shape
3. This does not take into account binding affinity magnitude
4. This analysis is only as good as the research – obviously, incorrect or incomplete medical research would skew these results
Spirit of the Coast Analytics strives to report medical intelligence pertaining to neurodegenerative & neurodevelopmental disorders to include Alzheimer’s Disease, Parkinson’s Disease, Rett Syndrome, Angelman Syndrome, Fragile X, and more.
We follow ongoing trends in clinical research, recap important peer-reviewed medical journals, and chronicle ongoing events at Anavex Life Sciences corp. ($AVXL), which we believe may have the most promising emerging therapeutics cross-central nervous system (CNS).
If you wish to learn more about Spirit of the Coast Analytics or leave a tip, more information is available at the link below.
Website Home: https://www.sotcanalytics.com/
If you’d like to help me go to AAIC 2023, please consider donating here:
https://www.gofundme.com/f/attend-aaic-2023-alzheimers-conference
If you wish to learn more about Anavex Life Sciences, more information is available at the links below.
Website Home: https://www.anavex.com/
Educational Video: https://www.anavex.com/vnrjune2022
If you’d like to use the STRING and KEGG Database you can do so here:
https://string-db.org/
https://www.kegg.jp/kegg/
source
